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recipient. Four studies were published which were het- these questions will certainly make for some interesting
erogeneous in their findings (Glaser et al., 2002; biology and perhaps future therapies.
Laflamme et al., 2002; Muller et al., 2002; Quaini et al.,
2002). Two studies found ample evidence of Y chromo- Leslie A. Leinwand
some-bearing cardiac myocytes in the transplanted Department of Molecular, Cellular,
hearts. A second study found this to be a very rare and Developmental Biology
finding and questioned its significance. A third report University of Colorado
found no evidence of Y chromosome-bearing cardiac Boulder, Colorado 80309
myocytes. Multiple editorials then appeared, with much
finger pointing about these discrepancies and the vari- Selected Reading
ous parties each claiming that their own techniques
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chi-were superior. The source of this exceptional furor ap-
menti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., et al.pears to lie in the potential for medical therapy that
(2003). Cell 114, this issue, 763–776.these studies hold. The source of the cells from the
Glaser, R., Lu, M.M., Narula, N., and Epstein, J.A. (2002). Circulationvarious recipients remains unknown.
106, 17–19.In addition to circulating stem cells, there has been
Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J.,considerable interest in the existence of resident stem
Majesky, M.W., Entman, M.L., Michael, L.H., Hirschi, K.K., andcells in tissues other than the bone marrow. The article
Goodell, M.A. (2001). J. Clin. Invest. 107, 1395–1402.
by Beltrami et al. in this issue of Cell provides convincing
Krause, D.S., Theise, N.D., Collector, M.I., Henegariu, O., Hwang, S.,
evidence that there is a stem cell population that resides Gardner, R., Neutzel, S., and Sharkis, S.J. (2001). Cell 105, 369–377.
in the adult heart. The stem cells can be isolated and
Laflamme, M.A., Myerson, D., Saffitz, J.E., and Murry, C.E. (2002).
expanded in culture indefinitely. The cells were identified Circ. Res. 90, 634–640.
and then isolated from the hearts of older adult rats Leferovich, J.M., Bedelbaeva, K., Samulewicz, S., Zhang, X.M.,
(20–23 months of age). They are characterized based Zwas, D., Lankford, E.B., and Heber-Katz, E. (2001). Proc. Natl.
on the following pattern of cell surface markers: Lin, Acad. Sci. USA 98, 9830–9835.
c-Kit, CD45, CD34. These cells were able to differ- Muller, P., Pfeiffer, P., Koglin, J., Schafers, H.J., Seeland, U., Janzen,
entiate into cardiac myocytes, smooth muscle cells, and I., Urbschat, S., and Bohm, M. (2002). Circulation 106, 31–35.
endothelial cells in culture. However, in culture, the “dif- Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker,
R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T.,ferentiated” cells had an immature phenotype. To test
Pera, M., de la Riviere, A.B., et al. (2003). Circulation 107, 2733–2740.whether these cells could achieve full mature differentia-
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini,tion in vivo, they were injected into the myocardium of
F., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. (2001a).rats subjected to a myocardial infarction. These cells
Proc. Natl. Acad. Sci. USA 98, 10344–10349.formed new myocardium and the hearts exhibited func-
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li,tional improvement. In fact, the average infarct size was
B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., et al.greater in the treated animals than the controls, most
(2001b). Nature 410, 701–705.
likely because untreated animals did not survive with
Quaini, F., Urbanek, K., Beltrami, A.P., Finato, N., Beltrami, C.A.,
infarcts as large as those in the treated group. The cells Nadal-Ginard, B., Kajstura, J., Leri, A., and Anversa, P. (2002). N.
were also able to form endothelial and smooth muscle Engl. J. Med. 346, 5–15.
structures. One potential caveat for these findings would
be if the stem cells had fused with existing host cells—
this might appear to be differentiation when, in fact, it
would be hybrid cells giving the appearance of differenti-
ation. However, the Beltrami et al. study ruled this out Apoptosis: A Process
by a number of criteria, including showing that the num-
with a ()NAC for Complexityber of new myocytes is orders of magnitude higher than
the injected cells and stating that the DNA content of
the new cells is diploid and not tetraploid. The cells
purified from the adult rat heart satisfy all of the proper-
Most programmed cell deaths in the nematode C. ele-ties of cardiac stem cells. They are clonogenic, self-
gans require ced-3 caspase activity. In a recent paper,renewing, and able to give rise to at least three different
Bloss et al. (2003) reveal a new C. elegans death inhibi-cell types. Finally, they participate in the formation of
tor, icd-1, whose loss can promote apoptosis indepen-new, functional myocardium.
dently of ced-3.Despite the convincing nature of this study, there are
numerous interesting questions to be pursued. Multipo-
Apoptosis (or programmed cell death), a ubiquitoustent adult progenitor cells, or MAPCs, which have also
metazoan cell death process, is crucial for proper organ-been shown to have cardiogenic potential, are charac-
ismal development, maintenance of cell number homeo-terized as being negative for the marker (c-Kit) used to
stasis, and elimination of diseased or otherwise harmfuldefine the cells in the Beltrami et al. study. In addition,
cells. In many instances, organismal life is impossiblethe fact that the adult stem cells in this study can form
in the absence of the machinery for cell death. Geneticendothelium, smooth muscle, and cardiac muscle is
studies in model organisms have proven a fertile groundconfounding, since these three cell types arise from
for the discovery and subsequent study of genes thatthree different cell lineages. Finally, if these cells exist
regulate apoptosis. Pioneering work by Horvitz and col-and lie dormant in the heart, why do they not mobilize
and divide in response to an injury? The answers to leagues in the 1980s identified three genes essential for
Cell
660
proper control of virtually all programmed cell deaths in number of programmed cell deaths still occurred in em-
bryos lacking ced-3 caspase activity (Shaham et al.,the nematode C. elegans. These genes, ced-3, ced-4,
and ced-9, were shown to act in a genetic pathway, 1999).
The inability to reconcile these observations with thesuch that ced-9 inhibits ced-4, ced-4 activates ced-3,
and ced-3 promotes cell death (Figure 1; Metzstein et al., notion of a single core pathway that regulates apoptosis
suggests that our understanding of cell death regulatory1998). Thus, ced-4 and ced-3 are proapoptotic genes,
whereas ced-9 is antiapoptotic. An avalanche of studies pathways may be inadequate to argue that the control
of the process evolved separately in different organisms.in the 1990s confirmed that the C. elegans apoptosis
genes and aspects of their interactions were conserved A recent paper by Bloss et al. (2003) not only confirms
that cell death regulation in nematodes is complex, butin vertebrates and in the fruit fly. bcl-2 and related genes
were found to be similar to ced-9, the Apaf-1 adaptor also introduces a new player into this complexity.
Bloss et al. discovered that inactivation of a C. elegansgene resembled ced-4, and ced-3 was shown to encode
a caspase protease. These studies suggested the exis- gene they named icd-1 (inhibitor of cell death-1 ) using
the method of RNA interference (RNAi) could result intence of a core pathway regulating apoptosis in all meta-
zoans. one of two phenotypes: early embryonic arrest with no
evidence of programmed cell death, or accumulation ofDespite the molecular similarities of death genes
across the animal kingdom, differences in the apparent large numbers of dying cells in animals that developed
past the early embryo stage. The authors showed thatregulation of the death process were also quickly recog-
nized. For example, in the fruit fly, a cascade of protein at least some of the extra dying cells they observed
in icd-1(RNAi) embryos should have normally survived.interactions and degradations involving the reaper/hid/
grim and IAP proteins was shown to be at least as impor- Thus, similarly to ced-9, icd-1 is an antiapoptotic gene
in C. elegans. The authors support this conclusion bytant in regulating caspase activity as the core apoptotic
pathway (Ryoo et al., 2002). In vertebrates, a set of demonstrating that global overexpression of icd-1 can
prevent normally occurring developmental cell deaths.mitochondrial factors, including cytochrome C, were
shown to regulate cell death (Wang, 2001). Neither of The early embryonic lethality of icd-1(RNAi) mutant
animals could not be prevented by eliminating ced-3 orthese modes of regulation was recognized in C. elegans,
raising the possibility that independent mechanisms for ced-4 functions in these embryos, suggesting that icd-1
may have other essential, nonapoptotic activities. How-regulating cell death may have evolved in different or-
ganisms. ever, the excessive number of dying cells in icd-1(RNAi)
embryos that progressed beyond early developmentBut was apoptosis understood enough to draw such
a conclusion, or were researchers poking at the same could be clearly prevented by eliminating ced-4 func-
tion, suggesting that icd-1 may normally engage theprocess but from different angles (much like the story
of the blind men and the elephant)? Several studies core apoptotic machinery to prevent the deaths of cells
that should normally live. Surprisingly, however, elimi-suggested that the C. elegans pathway was incomplete.
For example, localization studies of the proteins en- nating ced-3 activity prevented excessive cell death in
icd-1(RNAi) embryos just beginning to undergo morpho-coded by ced-9 and ced-4 demonstrated that both were
localized to mitochondria in living cells, and that the genesis, but did little to prevent excessive cell death in
more mature embryos and larvae.CED-4 protein translocated to nuclear membranes in
dying cells (Chen et al., 2000). These observations sug- icd-1 encodes the C. elegans version of the  subunit
of the nascent-polypeptide associated complex (NAC).gested that mitochondrial regulation of cell death may
be important in C. elegans after all. Even more puzzling The function of this complex is not very well understood;
however, there is evidence that it is involved in targetingwere observations indicating that cell death in C. ele-
gans could proceed in the absence of functional ced-3 of actively translated proteins to appropriate cellular
locations. Specifically, targeting of some proteins to mi-caspase. Ellis and Horvitz (1986) showed that death of
the C. elegans male linker cell could occur as scheduled tochondria may be regulated by the NAC (Rospert et
al., 2002). Consistent with this, Bloss et al. show thateven in animals harboring a mutant ced-3 gene. Another
study showed that cell death induced by overexpression ICD-1 protein is normally localized to mitochondria.
The studies of icd-1 add to observations suggestingof ced-4 could only be partially suppressed in a ced-3
mutant background (Shaham and Horvitz, 1996). And that alternatives to the core pathway of apoptosis may
exist for regulating cell demise in C. elegans (Figure 1).yet another study revealed that a small but consistent
Figure 1. Possible Interactions of the C. ele-
gans NAC with the Core Apoptosis Pathway
Black text and shapes indicate the estab-
lished core pathway. Blue text and shapes
indicate possible interactions of NAC with
this pathway.
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The studies also refocus attention on the possible role
of mitochondria in C. elegans apoptosis. As with clues
revealed in the midst of a good mystery novel, the paper
by Bloss et al. raises many questions. For example, how
does icd-1 function to inhibit apoptosis? Mutants in the
ced-9 gene have a phenotypic spectrum similar to that
of icd-1 mutants, including early embryonic arrest and
excess cell death in embryos that develop further (Hen-
gartner et al., 1992). Thus, one plausible hypothesis is
that ICD-1 protein shuttles nascent CED-9 protein on
ribosomes to mitochondria. This idea is easily tested by
examining CED-9 localization in icd-1(RNAi) animals.
Another question raised by the icd-1 studies is how cell
death can proceed independently of ced-3? Bloss et
al. suggest that another of the C. elegans caspases
(perhaps CSP-1B) may be activated by loss of ICD-1.
Alternatively, a novel caspase-independent pathway
may exist for killing cells in C. elegans. Expression of a
pan-caspase inhibitor protein such as the baculovirus
p35 protein in icd-1(RNAi) mutants might distinguish
between these possibilities.
The 2002 Nobel Prize awarded to Sydney Brenner,
John Sulston, and Bob Horvitz for their seminal work
on the genetic basis of apoptosis in C. elegans recog-
nized the efforts of these individuals in opening a new
area of study in Biology. Recent work, including the
paper by Bloss et al., suggests that we may have only
begun to scratch the surface of this important and inter-
esting process.
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